Case-control study for the identification of virological factors associated with fulminant hepatitis B.
about
Clinical relevance and public health significance of hepatitis B virus genomic variationsGenomic Diversity of Hepatitis B Virus Infection Associated With Fulminant Hepatitis B DevelopmentHepatitis E virus and fulminant hepatitis--a virus or host-specific pathology?Hepatitis B immunopathogenesis and immunotherapy.Fatal fulminant hepatitis caused by infection with subgenotype A1 hepatitis B virus with C1766T/T1768A core promoter mutations.Hepatitis B virus genotype B and mutations in basal core promoter and pre-core/core genes associated with acute-on-chronic liver failure: a multicenter cross-sectional study in China.Analysis of HBV genotype, drug resistant mutations, and pre-core/basal core promoter mutations in Korean patients with acute hepatitis B.Molecular analysis of the interspousal transmission of hepatitis B virus in two Japanese patients who acquired fulminant hepatitis B after 50 and 49 years of marriage.Management of hepatitis B virus-related acute liver failure.JSH Guidelines for the Management of Hepatitis B Virus Infection.Chronic hepatitis B carriers with acute on chronic liver failure show increased HBV surface gene mutations, including immune escape variants.High levels of hepatitis B virus after the onset of disease lead to chronic infection in patients with acute hepatitis B.Enhanced replication of hepatitis B virus with frameshift in the precore region found in fulminant hepatitis patients.Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure.Novel Genetic Variants of Hepatitis B Virus in Fulminant Hepatitis.Molecular Variants of the Precore, Core, and Core Promoter Regions of Hepatitis B Virus, and Their Clinical Significance
P2860
Q24644176-5A82A9DB-541A-48C5-865F-3C693A7DA5FFQ26796488-E912A300-5E4B-415B-84CF-554657D449A9Q36364737-FCC7E71A-21E6-46F4-85D4-3AC6EBC754B4Q38773364-44897E66-2105-404D-A8E5-0F8EE1263589Q40680143-752C494D-ECF2-49EE-99E8-B158B93118B9Q41094452-D4B5FC45-633D-4025-9586-5555631C7316Q41465525-8DAF7F3D-C811-40F6-913F-032C6F46739FQ42199419-EA772FEF-7BF4-4659-B83F-90275A46CC44Q42240045-93993505-CAFF-44AA-8436-179168F3E15CQ42244740-06C7EDBA-954D-494F-A296-F69909EE9104Q42633606-B3C7EA18-9225-4EE1-B231-9EE45DDA919BQ45351076-35AF2A78-2B09-4688-80DF-D9CE938B616CQ45363731-53F2FE57-86F4-4E8B-A907-62E4943DB792Q45365128-22FCCBAA-493F-4744-8D01-7B8E2CC7EFF3Q48093972-276A6993-ED73-4AB8-B1CA-2AC5B4753B05Q58808842-27CAEB1C-34AA-4DEA-8AF8-45C23426B00B
P2860
Case-control study for the identification of virological factors associated with fulminant hepatitis B.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Case-control study for the ide ...... ed with fulminant hepatitis B.
@en
Case-control study for the ide ...... ed with fulminant hepatitis B.
@nl
type
label
Case-control study for the ide ...... ed with fulminant hepatitis B.
@en
Case-control study for the ide ...... ed with fulminant hepatitis B.
@nl
prefLabel
Case-control study for the ide ...... ed with fulminant hepatitis B.
@en
Case-control study for the ide ...... ed with fulminant hepatitis B.
@nl
P2093
P2860
P1433
P1476
Case-control study for the ide ...... ed with fulminant hepatitis B.
@en
P2093
Atsunori Kusakabe
Eiji Tanaka
Fuminaka Sugauchi
Gotaro Yamada
Hiroshi Yatsuhashi
Isao Sakaida
Jong-Hon Kang
Junji Kato
Kazuaki Inoue
Masashi Mizokami
P2860
P304
P356
10.1111/J.1872-034X.2009.00519.X
P577
2009-04-23T00:00:00Z